Measuring outcomes of training in Empathetic Refutational Interviewing (ERI) for vaccine communication: Development and validation of the ERI Skills Inventory (ERISI)

衡量疫苗沟通中同理心反驳访谈(ERI)培训的效果:ERI技能清单(ERISI)的开发和验证

阅读:1

Abstract

Considering the complex nature of vaccine hesitancy and the vast amount of misinformation surrounding vaccination, training healthcare professionals (HCPs) in vaccine communication is important to ensure high vaccine uptake. Recently, a new vaccine communication approach, known as the Empathetic Refutational Interview (ERI), was developed to help HCPs in conversations with patients who have vaccine concerns. In the present study, we developed and validated the ERI Skills Inventory (ERISI) for assessing learning outcomes of training in ERI. The ERISI measures are (1) ERI-related knowledge, (2) ERI-related skills, and (3) confidence in using the ERI. A sample of 103 HCPs who took part in ERI training responded to the ERISI, as well as questions about their self-efficacy in vaccine consultations and preparedness to refute arguments against vaccination, before and after the training. At two follow-ups, they also reported their understanding and use of the ERI. Results showed that the ERISI is sensitive to positive changes in ERI knowledge and confidence as a result of training. Participants also showed increased use post-training of ERI skills to demonstrate empathy toward patients. However, no change was observed for ERI skills that refute misconceptions and inform patients using factual information, which participants tended to already use at pretest. ERI knowledge correlated positively with ERI skills at posttest. ERI confidence demonstrated both concurrent and predictive validity. The ERISI questionnaire is a valuable tool for assessing ERI training outcomes that can guide training development to ensure learning and future skill application.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。